Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2024 Nov 13;14:27831. doi: 10.1038/s41598-024-78897-z

Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer

Mohamed A Alfaleh 1,2, Omar Fahmy 3, Mohammed W Al-Rabia 4, Mohammed A S Abourehab 5,6, Osama A A Ahmed 1, Usama A Fahmy 1,, Helal H Alsulimani 1, Shaimaa M Badr-Eldin 1,7, Hibah M Aldawsari 1,8, Bander M Aldhabi 1, Awaad S Alharbi 1, Nabil A Alhakamy 1,8,9
PMCID: PMC11561141  PMID: 39537797

Retraction of: Scientific Reports 10.1038/s41598-022-24151-3, published online 14 November 2022

The Editors have retracted this Article. After publication, concerns were raised regarding irregularities in the flow cytometry plots presented in Fig. 7. The Authors have explained these irregularities, but have been unable to share the underlying raw data upon request.

Further checks by the Publisher found further potential irregularities in the data presented in Figs. 10 and 11. The Authors have stated that this and other cell line experiments in the study (Figs. 5–11) were performed by a third party, and the raw data are not available.

The Editors therefore no longer have confidence in the presented data.

The Publisher has not been able to obtain current email addresses for Mohamed A. Alfaleh and Usama A. Fahmy. None of the other Authors have responded to any correspondence from the Publisher about this retraction.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES